Proving the Business Case for the Internet of Things

Ping An takes AskBob medical AI to Singapore

Steve Rogerson
August 6, 2019

Chinese company Ping An has introduced its AskBob artificial intelligence (AI)-based medical decision support tool to Singapore through collaborations with SingHealth and the National University Health System (NUHS).
AskBob provides critical and up-to-date medical information to clinicians when dealing with patients at the point of care and for medical research and self-learning such as case discussions.
At the point of care, AskBob provides precise diagnosis and treatment recommendations for more than 1500 diseases. Unlike other clinical decision support systems, it is a knowledge-plus-data two-wheeled drive intelligent system based on millions of anonymous patient medical records, clinical guidelines and a core medical knowledge graph covering tens of millions of pieces of medical data. The treatment recommendations AskBob provides are authoritative, personalised and patient-centric.
For medical research and self-learning, AskBob makes use of Ping An's medical knowledge graph and natural language processing technologies to perform more user-friendly, intuitive and precise online searches and literature analyses. It can provide up-to-date literature analysis summaries and predict scientific research trends. It can also track the scholar team network in a certain research field to connect researchers around the world.
"We are delighted to cooperate with SingHealth and the National University Health System," said Xie Guotong, chief healthcare scientist of Ping An Group. “They are both authoritative healthcare institutions in Singapore. With Ping An's advanced healthcare technologies and through validating and customising AskBob with SingHealth and NUHS, we believe our smart decision support tool could effectively empower clinicians in Singapore, bringing better health outcomes for Singaporeans."
The collaboration with SingHealth, one of Singapore's largest public healthcare groups, started in April. It aims to provide doctors with personalised treatment recommendations for type-two diabetes patients at the point of care. Diabetes is a serious health issue in Singapore, with one in nine Singapore residents aged 18 to 69 having diabetes.
AskBob's recommendations can potentially help achieve better diabetes control and health outcomes, including reducing diabetic complications such as stroke and kidney failure.
"An AI-based clinical decision support system could potentially help doctors increase the accuracy and efficiency of diabetes treatment,” said Bee Yong Mong, head of the SingHealth Duke-NUS Diabetes Centre. “With the tool, we hope to better predict risks of complications and offer more personalised treatment recommendations to patients."
NUHS, the academic health sciences centre in Singapore, is piloting AskBob with clinicians for smart literature search and medical research trend analysis.
"More than a search engine, AskBob uses a medical knowledge graph and a natural language processing engine to empower precise literature analysis without giving you information that you don't need,” said Ngiam Kee Yuan, group chief technology officer from NUHS. “This is the power of using AskBob. I believe it will be extremely helpful for clinicians in medical research and case discussions."
Using the group's three core technologies of artificial intelligence, blockchain and cloud computing, Ping An provides integrated diagnosis and treatment, including smart triage and guidance, smart disease prediction, smart medical imaging screening and diagnosis, smart clinical decision support, and smart patient follow-up and education. It is available to nearly 800 million patients in more than 70 cities in China and countries in south-east Asia.